Search

Search Constraints

You searched for: Author/Creator Qiu, Junshan

Search Results

5. FDA Approval Summary: Ruxolitinib for Treatment of Steroid‐Refractory Acute Graft‐Versus‐Host Disease. (22nd October 2019)